Literature DB >> 26258287

Resistant Catatonia in a High-Functioning Autism Spectrum Disorder Patient Successfully Treated with Amantadine.

Pierre Ellul1, Jean Y Rotgé1, Walid Choucha1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26258287     DOI： 10.1089/cap.2015.0064

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  5 in total

1.  [German version of the Northoff catatonia rating scale (NCRS-dv) : A validated instrument for measuring catatonic symptoms].

Authors:  D Hirjak; P A Thomann; G Northoff; K M Kubera; R C Wolf
Journal:  Nervenarzt       Date:  2017-07       Impact factor: 1.214

Review 2.  Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology.

Authors:  Sean A Rasmussen; Michael F Mazurek; Patricia I Rosebush
Journal:  World J Psychiatry       Date:  2016-12-22

3.  Associations Between Amantadine Usage, Gait, and Cognition in PSP: A post-hoc Analysis of the Davunetide Trial.

Authors:  Marian L Dale; Barbara H Brumbach; Adam L Boxer; Amie L Hiller
Journal:  Front Neurol       Date:  2020-12-21       Impact factor: 4.003

Review 4.  Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence.

Authors:  Daniel Felipe Ariza-Salamanca; María Gabriela Corrales-Hernández; María José Pachón-Londoño; Isabella Hernández-Duarte
Journal:  Front Mol Neurosci       Date:  2022-09-29       Impact factor: 6.261

Review 5.  Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Clin Med Insights Pediatr       Date:  2016-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.